Alfons Lawen

5.1k total citations · 1 hit paper
81 papers, 4.3k citations indexed

About

Alfons Lawen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Nutrition and Dietetics. According to data from OpenAlex, Alfons Lawen has authored 81 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 10 papers in Nutrition and Dietetics. Recurrent topics in Alfons Lawen's work include Signaling Pathways in Disease (20 papers), Mitochondrial Function and Pathology (13 papers) and ATP Synthase and ATPases Research (12 papers). Alfons Lawen is often cited by papers focused on Signaling Pathways in Disease (20 papers), Mitochondrial Function and Pathology (13 papers) and ATP Synthase and ATPases Research (12 papers). Alfons Lawen collaborates with scholars based in Australia, Germany and Italy. Alfons Lawen's co-authors include Jennifer Ly, David R Grubb, Darius J.R. Lane, Vito De Pinto, François Vaillant, Rainer Zocher, Mark A. Baker, Ernst J. Wolvetang, Angela Messina and René Traber and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Alfons Lawen

80 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The mitochondrial membrane potential (Δψm) in apoptosis; an update

2003 1.4k citations Jennifer Ly, David R Grubb et al. APOPTOSIS profile →

Peers

Countries citing papers authored by Alfons Lawen

Since Specialization

Citations

This map shows the geographic impact of Alfons Lawen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfons Lawen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfons Lawen more than expected).

Fields of papers citing papers by Alfons Lawen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfons Lawen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfons Lawen. The network helps show where Alfons Lawen may publish in the future.

Co-authorship network of co-authors of Alfons Lawen

This figure shows the co-authorship network connecting the top 25 collaborators of Alfons Lawen. A scholar is included among the top collaborators of Alfons Lawen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfons Lawen. Alfons Lawen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integration of intracellular signaling: Biological analogues of wires, processors and memories organized by a centrosome 3D reference system 2018 ·Biosystems ·(unknown), Alfons Lawen, Muhammad Aslam, Antonella Pantaleo, Carlota Saldanha, (unknown), (unknown), Jack A. Tuszyński	15
2	Is erythroferrone finally the long sought-after systemic erythroid regulator of iron? 2015 ·World Journal of Biological Chemistry ·Alfons Lawen	8
3	Prediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modeling 2015 ·BMC Systems Biology ·AKM Azad, Alfons Lawen, Jonathan M. Keith	18
4	Biosynthesis of cyclosporins and other natural peptidyl prolyl cis/trans isomerase inhibitors 2014 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Alfons Lawen	15
5	Mammalian Iron Homeostasis in Health and Disease: Uptake, Storage, Transport, and Molecular Mechanisms of Action 2012 ·Antioxidants and Redox Signaling ·Alfons Lawen, Darius J.R. Lane	177
6	Inactivation of astrocytic glutamine synthetase by hydrogen peroxide requires iron 2010 ·Neuroscience Letters ·(unknown), Ralf Dringen, Alfons Lawen, Stephen R. Robinson	19
7	Voltage‐dependent anion‐selective channel (VDAC) in the plasma membrane 2010 ·FEBS Letters ·Vito De Pinto, Angela Messina, Darius J.R. Lane, Alfons Lawen	143
8	Targeting mitochondrial permeability in cancer drug development 2008 ·Molecular Nutrition & Food Research ·Michael V. Berridge, Patries M. Herst, Alfons Lawen	30
9	Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents 2006 ·Recent Patents on Anti-Cancer Drug Discovery ·Stephen J. Ralph, Pauline Low, Lan‐Feng Dong, Alfons Lawen, Jiřı́ Neužil	85
10	An improved purification procedure for cyclosporin synthetase 2005 ·Protein Expression and Purification ·Tony Velkov, (unknown), Alfons Lawen	5
11	Transplasma membrane electron transport: enzymes involved and biological function 2003 ·Redox Report ·Jennifer Ly, Alfons Lawen	74
12	Apoptosis—an introduction 2003 ·BioEssays ·Alfons Lawen	363
13	The mitochondrial membrane potential (Δψm) in apoptosis; an update breakdown → 2003 ·APOPTOSIS ·Jennifer Ly, David R Grubb, Alfons Lawen	1405
14	Cyclosporin A, FK506 and rapamycin produce multiple, temporally distinct, effects on memory following single-trial, passive avoidance training in the chick 2002 ·Brain Research ·Pauleen C. Bennett, L.D. Schmidt, Alfons Lawen, (unknown), Kim T. Ng	16
15	Peptidyl‐prolyl‐cis/trans‐isomerase activity may be necessary for memory formation 1998 ·FEBS Letters ·Pauleen C. Bennett, (unknown), Weiqin Zhao, Alfons Lawen, Kim T. Ng	20
16	Protein tyrosine kinase inhibitors prevent didemnin B‐induced apoptosis in HL‐60 cells 1996 ·FEBS Letters ·Karina L Johnson, François Vaillant, Alfons Lawen	34
17	Reversal of multidrug resistance by novel cyclosporin A analogues and the cyclopeptolide SDZ 214-103 biosynthesized in vitro 1995 ·Journal of Cancer Research and Clinical Oncology ·(unknown), G. Steinheider, Alfons Lawen, René Traber, Alfred G. Hildebrandt	6
18	The universality of bioenergetic disease: The role of mitochondrial mutation and the putative inter-relationship between mitochondria and plasma membrane NADH oxidoreductase 1994 ·Molecular Aspects of Medicine ·Alfons Lawen, Ryan D. Martinus, Gabrielle L. McMullen, Phillip Nagley, François Vaillant, Ernst J. Wolvetang, A.W. Linnane	56
19	Isolation and Partial Characterization of Cyclosporin Synthetase from a Cyclosporin Non-Producing Mutant ofBeauveria nivea 1990 ·Biological Chemistry Hoppe-Seyler ·(unknown), Alfons Lawen, Rainer Zocher, Horst Kleinkauf	12
20	Insulin‐induced S6 kinase activation in HeLa cells and its reversal by hyperthermic stress 1989 ·European Journal of Biochemistry ·Matthias Burger, Alfons Lawen, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact